Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome

被引:24
|
作者
Jonker, L. A. [1 ]
Lebbink, C. A. [1 ,2 ]
Jongmans, M. C. J. [2 ,3 ]
Nievelstein, R. A. J. [2 ,4 ]
Merks, J. H. M. [2 ]
Nieveen van Dijkum, E. J. M. [5 ]
Links, T. P. [6 ]
Hoogerbrugge, N. [7 ]
van Trotsenburg, A. S. P. [8 ]
van Santen, H. M. [1 ,2 ]
机构
[1] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Endocrinol, POB 85090, NL-3508 AB Utrecht, Netherlands
[2] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Radiol & Nucl Med, Utrecht, Netherlands
[5] Univ Amsterdam, Med Ctr, Dept Surg, Canc Ctr Amsterdam, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands
[7] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands
[8] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Endocrinol, Med Ctr, Amsterdam, Netherlands
关键词
Differentiated thyroid carcinoma; PTEN hamartoma tumor syndrome; pediatric; Thyroid carcinoma surveillance program; Thyroid cancer genetics; COWDEN SYNDROME; GERMLINE PTEN; PHOSPHATIDYLINOSITOL; 3-KINASE/AKT; CANCER; RISK; INDIVIDUALS; ADOLESCENTS; DISEASE;
D O I
10.1159/000508872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:PTEN hamartoma tumor syndrome (PHTS) represents a group of syndromes caused by a mutation in thePTENgene. Children with a germlinePTENmutation have an increased risk of developing differentiated thyroid carcinoma (DTC). Several guidelines have focused on thyroid surveillance in these children, but studies substantiating these recommendations are lacking.Objective:The present study intends to provide the available evidence for a thyroid carcinoma surveillance program in children with PHTS.Methods:An extensive literature search was performed to identify all studies on DTC in pediatric PHTS patients. Two pediatric cases are presented to illustrate the pros and cons of thyroid carcinoma surveillance. Recommendations for other patient groups at risk for DTC were evaluated. Consensus within the study team on recommendations for children with PHTS was reached by balancing the incidence and behavior of DTC with the pros and cons of thyroid surveillance, and the different surveillance methods.Results:In 5 cohort studies the incidence of DTC in childhood ranged from 4 to 12%. In total 57 cases of DTC and/or benign nodular disease in pediatric PHTS patients were identified, of which 27 had proven DTC, with a median age of 12 years (range 4-17). Follicular thyroid carcinoma (FTC) was diagnosed in 52% of the pediatric DTC patients. No evidence was found for a different clinical behavior of DTC in PHTS patients compared to sporadic DTC.Conclusions:Children with PHTS are at increased risk for developing DTC, with 4 years being the youngest age reported at presentation and FTC being overrepresented. DTC in pediatric PHTS patients does not seem to be more aggressive than sporadic DTC.Recommendations:Surveillance for DTC in pediatric PHTS patients seems justified, as early diagnosis may decrease morbidity. Consensus within the study team was reached to recommend surveillance from the age of 10 years onwards, since at that age the incidence of DTC seems to reach 5%. Surveillance for DTC should consist of yearly neck palpation and triennial thyroid ultrasound. Surveillance in children with PHTS should be performed in a center of excellence for pediatric thyroid disease or PHTS.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 50 条
  • [1] Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations
    Plitt, Gilman
    Brewer, Takae
    Yehia, Lamis
    Jin, Judy
    Shin, Joyce
    Eng, Charis
    THYROID, 2022, 32 (09) : 1094 - 1100
  • [2] Thyroid Nodules and Cancer in Children with PTEN Hamartoma Tumor Syndrome
    Smith, Jessica R.
    Marqusee, Ellen
    Webb, Susan
    Nose, Vania
    Fishman, Steven J.
    Shamberger, Robert C.
    Frates, Mary C.
    Huang, Stephen A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (01): : 34 - 37
  • [3] The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance
    Baran, Julia A.
    Tsai, Steven D.
    Isaza, Amber
    Brodeur, Garrett M.
    MacFarland, Suzanne P.
    Zelley, Kristin
    Adams, Denise M.
    Franco, Aime T.
    Bauer, Andrew J.
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 93 (11-12): : 634 - 642
  • [4] Surveillance in children with PTEN Hamartoma Tumor Syndrome: the yield of yearly thyroid ultrasound in a Dutch expertise centre
    Bormans, Esther
    Schuurs-Hoeijmakers, Janneke
    van Setten, Petra
    Hendricks, Linda
    Drissen, Meggie
    Gotthardt, Martin
    Claahsen, Hedi
    Hoogerbrugge, Nicoline
    Schieving, Jolanda
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1252 - 1253
  • [5] Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome
    Smith, Jessica R.
    Liu, Enju
    Church, Alanna J.
    Asch, Elizabeth
    Cherella, Christine E.
    Srivastava, Siddharth
    Kamihara, Junne
    Wassner, Ari J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (03): : E1121 - E1130
  • [6] Thyroid disease in children and adolescents with PTEN hamartoma tumor syndrome (PHTS)
    Michaela Plamper
    Felix Schreiner
    Bettina Gohlke
    Janina Kionke
    Eckard Korsch
    James Kirkpatrick
    Mark Born
    Stefan Aretz
    Joachim Woelfle
    European Journal of Pediatrics, 2018, 177 : 429 - 435
  • [7] Thyroid disease in children and adolescents with PTEN hamartoma tumor syndrome (PHTS)
    Plamper, Michaela
    Schreiner, Felix
    Gohlke, Bettina
    Kionke, Janina
    Korsch, Eckard
    Kirkpatrick, James
    Born, Mark
    Aretz, Stefan
    Woelfle, Joachim
    EUROPEAN JOURNAL OF PEDIATRICS, 2018, 177 (03) : 429 - 435
  • [8] Thyroid pathology, a clue to PTEN hamartoma tumor syndrome
    Lee, Yurimi
    Oh, Young Lyun
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2023, 57 (03) : 178 - 183
  • [9] “Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)”
    Gerdi Tuli
    Jessica Munarin
    Alessandro Mussa
    Diana Carli
    Roberto Gastaldi
    Paola Borgia
    Maria Cristina Vigone
    Marco Abbate
    Giovanni Battista Ferrero
    Luisa De Sanctis
    Endocrine, 2021, 74 : 632 - 637
  • [10] Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)
    Tuli, Gerdi
    Munarin, Jessica
    Mussa, Alessandro
    Carli, Diana
    Gastaldi, Roberto
    Borgia, Paola
    Vigone, Maria Cristina
    Abbate, Marco
    Ferrero, Giovanni Battista
    De Sanctis, Luisa
    ENDOCRINE, 2021, 74 (03) : 632 - 637